APA-viite

Arrillaga-Romany, I., Sahebjam, S., Picconi, D., Campian, J., Giglio, P., Drappatz, J., . . . Gerstner, E. (2019). ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro Oncol.

Chicago-tyylinen lähdeviittaus

Arrillaga-Romany, Isabel, et al. "ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA." Neuro Oncol 2019.

MLA-viite

Arrillaga-Romany, Isabel, et al. "ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA." Neuro Oncol 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.